Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA AUTHORIZED GENERIC 2.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| asegua therapeutics llc | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Ledipasvir and Sofosbuvir | Ledipasvir and Sofosbuvir | tablet, film coated, oral | 72626-2601NDA AUTHORIZED GENERIC |
| Sofosbuvir and Velpatasvir | Velpatasvir and Sofosbuvir | tablet, film coated, oral | 72626-2701NDA AUTHORIZED GENERIC |
Enquiry
Common questions
- Is Asegua Therapeutics LLC FDA approved?
- Asegua Therapeutics LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Asegua Therapeutics LLC make?
- 2 products are listed under Asegua Therapeutics LLC in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.